At their first visit, patients who had an OI during the study period had a lower CD4 count compared to those who did not have an OI during the study period (with OI: median 112; IQR 46–242 vs without OI: median 199; IQR 99–343). The gene discussed is CD4; the disease is osteogenesis imperfecta.